TOXICITY PREVENTION WITH AMIFOSTINE IN PEDIATRIC OSTEOSARCOMA PATIENTS TREATED WITH CISPLATIN AND DOXORUBICIN

Author： Gallegos-Castorena Sergio Martínez-Avalos Armando Mohar-Betancourt Alejandro Guerrero-Avendaño Guadalupe Zapata-Tarrés Martha Medina-Sansón Aurora

Publisher： Informa Healthcare

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.24, Iss.6, 2007-07, pp. : 403-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pediatric extraskeletal osteosarcoma

By Beall Douglas Ly Justin Bell Jayson Parker Ellen John Christopher Babb Julie Stapp Annette

Pediatric Radiology, Vol. 38, Iss. 5, 2008-05 ,pp. : 579-582

Springer Publishing Company

Access to resources Recommend Favorite

Amifostine Protects Against Cisplatin-Induced Nephrotoxicity in a Child with Medulloblastoma

By Hayek Mohammed

Pediatric Hematology and Oncology, Vol. 20, Iss. 3, 2003-04 ,pp. : 253-256

Informa Healthcare

Access to resources Recommend Favorite

SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE

By Sastry Jairam Kellie Stewart

Pediatric Hematology and Oncology, Vol. 22, Iss. 5, 2005-07 ,pp. : 441-445

Informa Healthcare

Access to resources Recommend Favorite

INCIDENCE OF SEIZURES IN PEDIATRIC CANCER PATIENTS TREATED WITH IMIPENEM/CILASTATIN

By Karadeniz Ceyda Oğuz Aynur Canter Berna Serdaroğlu Ayşe

Pediatric Hematology and Oncology, Vol. 17, Iss. 7, 2000-10 ,pp. : 585-590

Informa Healthcare

Access to resources Recommend Favorite

COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION

By Huh Winston W. Jaffe Norman Durand Jean-Bernard Munsell Mark F. Herzog Cynthia E.

Pediatric Hematology and Oncology, Vol. 27, Iss. 7, 2010-09 ,pp. : 546-557

Informa Healthcare

Access to resources Recommend Favorite